The Cooper Companies Inc (COO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
The Cooper Companies Inc   (NASDAQ: COO)
 

The Cooper Companies Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

The Cooper Companies Inc inventory turnover ratio, the The Cooper Companies Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.67 in the second quarter 2026, yet the ratio remained below the average, as COO's market remain challenging.Average inventory processing period, for the The Cooper Companies Inc in Apr 30 2026 quarter, has decreased to 219 days, compare to 221 days, in the Jan 31 2026 quarter.

Within Healthcare sector 237 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1198 in the first quarter 2026, to 1605.

COO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is The Cooper Companies Inc Market Share?

What is Inventory Turnover Ratio?




COO Inventory Turnover Ratio (Apr 30 2026)
II. Quarter
(Jan 31 2026)
I. Quarter
(Oct 31 2025)
IV. Quarter
(Jul 31 2025)
III. Quarter
(Apr 30 2025)
II. Quarter
Y / Y Inventory Growth 1.83 % 3.97 % 5.39 % 13.05 % 13.53 %
Y / Y Cost of Sales Growth 7.12 % 7.89 % 21.81 % 8.55 % 3.86 %
Inventory Turnover Ratio (TTM) 1.67 1.65 1.63 1.57 1.58
COO's Total Ranking # 1605 # 1198 # 1506 # 1401 # 1248
Average inventory processing period 219 222 223 233 231
Seq. Inventory Growth 2.28 % 3.59 % -3.97 % 0.08 % 4.44 %
Seq. Cost of Sales Growth 5.49 % -20.96 % 12.77 % 13.93 % 6.25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 238
Overall Market # 1605

Inventory Turnover Ratio Statistics
High Average Low
1.91 1.69 1.25
(Oct 31 2022)   (Jul 31 2013)




Financial Statements
The Cooper Companies Inc 's Inventories $ 896 Millions Visit COO's Balance sheet
The Cooper Companies Inc 's Cost of Revenues TTM $ 1,457 Millions Visit COO's Income Statement
What are COO's Sales? Visit COO's Sales by Segment

Other Inventory Turnover Ratios
The Cooper Companies Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
COO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for COO's Competitors
Inventory Turnover Ratio for COO's Suppliers
Inventory Turnover Ratio for COO's Customers

You may also want to know
COO's Sales Growth Rates COO's Pe Price to earnings ratio COO's Receivables Turnover Ratio COO's Stock Quote
COO's Net Income Growth Rates COO's Ps Price to Sales ratio COO's Sales per Employee COO's Asset Turnover Ratio
COO's Net Margin COO's Pb Price to Book ratio COO's Financial Strength Ratios COO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Apr 30 2026 Inventories at quarter ending Apr 30 2026
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions
Zai Lab Limited  4.32 $ 190.383  Millions$ 44  Millions
Inotiv Inc   4.25 $ 175.895  Millions$ 41  Millions
Cryoport inc   4.23 $ 96.609  Millions$ 23  Millions
Teva Pharmaceutical Industries Limited  4.22 $ 8,317.000  Millions$ 1,971  Millions
Incyte Corporation  4.21 $ 403.465  Millions$ 96  Millions
Electromed Inc   4.16 $ 14.195  Millions$ 3  Millions
Vericel Corporation  4.15 $ 73.494  Millions$ 18  Millions
Sharps Technology Inc   4.12 $ 3.585  Millions$ 1  Millions
Coherus Oncology inc   4.11 $ 14.975  Millions$ 4  Millions
Novocure Limited  4.08 $ 167.287  Millions$ 41  Millions
Lifeward ltd   4.08 $ 13.275  Millions$ 3  Millions
Ge Healthcare Technologies Inc   4.04 $ 9,262.000  Millions$ 2,294  Millions
Koru Medical Systems Inc   3.99 $ 16.468  Millions$ 4  Millions
3m Company  3.94 $ 15,087.000  Millions$ 3,830  Millions
Iridex Corp  3.92 $ 32.247  Millions$ 8  Millions
Myomo Inc   3.88 $ 14.000  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.84 $ 71.976  Millions$ 19  Millions
Alpha Teknova Inc   3.79 $ 26.988  Millions$ 7  Millions
Escalon Medical Corp   3.79 $ 6.698  Millions$ 2  Millions
Evolus Inc   3.71 $ 103.000  Millions$ 28  Millions
Abbvie Inc   3.70 $ 18,420.000  Millions$ 4,975  Millions
Biocryst Pharmaceuticals Inc   3.67 $ 19.884  Millions$ 5  Millions
Neuraxis Inc   3.61 $ 0.665  Millions$ 0  Millions
Mirum Pharmaceuticals Inc   3.50 $ 85.221  Millions$ 24  Millions
Sonoma Pharmaceuticals Inc   3.46 $ 12.114  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.45 $ 461.746  Millions$ 134  Millions
Exelixis Inc   3.41 $ 84.478  Millions$ 25  Millions

Date modified: 2026-06-08T22:19:43+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.